Botulinum toxin B

N/A

Report date: 2026/05/23 20:00:57

Base Information

Drug NameBotulinum toxin B
Drug Alias NameRimabotulinumtoxinBBotulinum toxin type BNerBlocMyoblocNeurobloc +[9] 
ClassificationBiologics > Protein drugs > ToxinNatural product/Extract > Microbial extract
Mechanisms of ActionVesicle associated membrane protein 1 inhibitorsVesicle associated membrane protein 2 inhibitors
TargetsVesicle associated membrane protein 1Vesicle associated membrane protein 2
Therapy Area/IndicationsSpinal Cord InjuriesAmyotrophic Lateral SclerosisTorticollis +[9] 
Global Approved IndicationsTorticollis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2000/12/08
Country/TerritoryCzechiaUnited StatesPoland +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesUs Worldmeds Holdings Llc
China Registration ClassN/A

Develop Information

Active CompaniesElan Pharmaceuticals IncSupernus Pharmaceuticals Inc
Inactive CompaniesSolstice Neurosciences LLCUT Health San AntonioStanford University +[6] 
Active IndicationsSpinal Cord InjuriesTorticollisStroke +[7] 
Inactive IndicationsAmyotrophic Lateral SclerosisSialorrhea

Other Information

ATC CodeM03AX01
Related LinksWikipediaDrugBank